ClinicalTrials.Veeva

Menu

Daily Chlorexidine Bath for Health Care Associated Infection Prevention (CLEAN-IT)

H

Hospital do Coracao

Status and phase

Completed
Phase 3

Conditions

Catheter-Associated Urinary Tract Infection
Ventilator Associated Pneumonia
Central Line-associated Bloodstream Infection (CLABSI)
Health Care Associated Infection

Treatments

Other: Usual Baths
Other: 2% chlorhexidine digluconate solution with surface-active agents

Study type

Interventional

Funder types

Other

Identifiers

NCT05485051
ip_hcor_cleanit

Details and patient eligibility

About

Cluster randomized controlled trial comparing two bathing strategies in critically ill patients. The intervention group will receive daily bathing with chlorhexidine. The control group will receive usual care.

Full description

Healthcare-associated infections (HAI) are common complications in critically ill patients and are associated with increased costs, higher length of stay, and higher morbimortality. Data shows that daily chlorhexidine baths might be associated with lower HAI rates in a broad population of critically ill patients. The purpose of this trial is to evaluate the effect of daily bathing with chlorhexidine compared to usual baths (soap and water) on HAI in critically ill patients.

Enrollment

15,730 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients ≥ 18 years/old admitted to the participants's ICUs

Exclusion criteria

  • History of chlorhexidine allergy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

15,730 participants in 2 patient groups

Chlorhexidine baths
Experimental group
Description:
All patients in the cluster randomized to the intervention arm will receive baths using a 2% chlorhexidine digluconate solution with surface-active agents during the intervention period. All other infection control and cleaning procedures will be performed according to the current practice in each center.
Treatment:
Other: 2% chlorhexidine digluconate solution with surface-active agents
Usual baths
Active Comparator group
Description:
All patients in the cluster randomized to the intervention arm will receive baths using soap and water according to the current practice in each center during the intervention period. All other infection control and cleaning procedures will be performed according to the current practice in each center.
Treatment:
Other: Usual Baths

Trial contacts and locations

16

Loading...

Central trial contact

Alexandre B. Cavalcanti, M.D; Bruno M Tomazini, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems